PTU-069 Effect of Adalimumab on Patients with Moderate to Severe Ulcerative Colitis in UK Clinical Practice Setting: Results from Inspirada

P Irving; F Cummings; SL Bloom; A Lazar; AM Robinson; BL Pappalardo; M Bereswill; M Skup; N Chen; T Finney-Hayward; S Wang; RB Thakkar; S Travis

doi:10.1136/gutjnl-2016-312388.154

Article info

BSG 2016

PTU-069 Effect of Adalimumab on Patients with Moderate to Severe Ulcerative Colitis in UK Clinical Practice Setting: Results from Inspirada

Authors

P Irving 1Guy’s and St. Thomas’ Hospitals, London PubMed articles Google scholar articles
F Cummings 2University Hospital Southampton, Southampton PubMed articles Google scholar articles
SL Bloom 3University College London Hospitals, London, UK PubMed articles Google scholar articles
A Lazar 4AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany PubMed articles Google scholar articles
AM Robinson 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
BL Pappalardo 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
M Bereswill 4AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany PubMed articles Google scholar articles
M Skup 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
N Chen 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
T Finney-Hayward 6AbbVie Ltd., Berkshire PubMed articles Google scholar articles
S Wang 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
RB Thakkar 5AbbVie Inc., North Chicago, United States PubMed articles Google scholar articles
S Travis 7Oxford University Hospitals, Oxford, UK PubMed articles Google scholar articles

Citation

Irving P, Cummings F, Bloom S, et al

PTU-069 Effect of Adalimumab on Patients with Moderate to Severe Ulcerative Colitis in UK Clinical Practice Setting: Results from Inspirada

Gut 2016;65:A86-A87.

Publication history

First published August 17, 2016.

Online issue publication

February 10, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password